Everest Group, Ltd. EG is well-poised to gain on the back of product diversification, higher income from the fixed income portfolio, favorable estimates, strong renewal retention, prudent capital deployment and a solid capital position. Growth Projections The Zacks Consensus Estimate for Everest Group’s 2024 revenues is pegged at $17.70 billion, implying a year-over-year improvement of 21.1%. The consensus estimate for 2025 earnings per share and revenues indicates an increase of 12.5% and 11.7%, respectively, from the corresponding 2024 estimates. Earnings have grown 40.4% in the past five years, better than the industry average of 9%. Earnings Surprise History EG surpassed earnings estimates in each of the last four quarters, the average being 37.54%. Zacks Rank & Price Performance Everest Group currently carries a Zacks Rank #3 (Hold). Over the past year, the stock has gained 11.4% compared with the industry’s growth of 25.2%. Zacks Investment Research Image Source: Zacks Investment Research Return on Equity Everest Group’s annualized after-tax operating income return on equity was 20% in the first quarter, which expanded 280 basis points (bps) year over year. Its return on equity for the trailing 12 months is 24.9%, which expanded 1,190 bps year over year. This reflects its efficiency in utilizing its shareholders’ funds. Style Score The insurer has a VGM Score of A. The VGM Score helps identify stocks with the most attractive value, best growth and the most promising momentum. Business Tailwinds Global presence, product diversification, rate increase and high retention rate continue to drive EG’s overall growth. The Insurance segment is poised to benefit from an increase in property and short tail business and a rise in specialty casualty business. On the other hand, leveraging opportunities stemming from the continued disruption and evolution of the reinsurance market should poise the Reinsurance segment for growth. Net investment income stands to benefit from higher income from the fixed income portfolio, increase in limited partnership income, rise in dividend income from the equity portfolio and higher income from other invested assets. An improved interest rate environment adds to the upside. Everest Group has a strong capital position, banking on sufficient cash generation capabilities and benefits from capital adequacy, financial flexibility, long-term operating performance and traditional risk management capabilities. The company boasts a consistent increase in dividends, with the metric witnessing an eight-year (2016-2023) CAGR of 34.9%. The insurer targets a total shareholder return on equity of more than 17% from 2024 to 2026, reflecting robust and well-diversified earnings power. EG boasts consistent and industry-leading shareholder returns. Everest Group has an impressive Growth Score of B. This style score helps analyze the growth prospects of a company. However, the insurer has been experiencing an increase in expenses due to higher incurred losses and loss adjustment expenses, commission, brokerage, taxes and fees and other underwriting expenses. The company should continue to generate revenues at a higher magnitude than expenses. Stocks to Consider Some better-ranked stocks from the multi-line insurance industry are Hamilton Insurance Group, Ltd. HG, MGIC Investment Corporation MTG and EverQuote, Inc. EVER. While Hamilton Insurance sports a Zacks Rank #1 (Strong Buy), MGIC Investment and EverQuote carry a Zacks Rank #2 (Buy) each at present. You can see the complete list of today’s Zacks #1 Rank stocks here. The Zacks Consensus Estimate for Hamilton Insurance’s 2024 and 2025 earnings implies year-over-year growth of 60.6% and 13.2%, respectively. In the past year, shares of HG have gained 16.7%. The Zacks Consensus Estimate for HG’s 2024 and 2025 revenues implies year-over-year growth of 45% and 11%, respectively. EverQuote has a solid track record of beating earnings estimates in each of the trailing four quarters, the average being 65.16%. In the past year, shares of EVER have skyrocketed 256.9%. The Zacks Consensus Estimate for EVER’s 2024 and 2025 earnings implies year-over-year growth of 103% and 270%, respectively. MGIC Investment has a solid track record of beating earnings estimates in each of the trailing four quarters, the average being 15.45%. In the past year, shares of MTG have jumped 42.8%. The Zacks Consensus Estimate for MTG’s 2024 and 2025 revenues implies year-over-year growth of 4.6% and 4.8%, respectively. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report MGIC Investment Corporation (MTG):Free Stock Analysis Report EverQuote, Inc. (EVER):Free Stock Analysis Report Everest Group, Ltd. (EG):Free Stock Analysis Report Hamilton Insurance Group, Ltd. (HG):Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research
Here's Why Investors Should Retain Everest Group (EG) Stock
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...